The DiGEM trial protocol - A randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes [ISRCTN47464659]

被引：25

作者：

Farmer A. ^{[1
,5
]}

Wade A. ^{[1
]}

French D.P. ^{[2
]}

Goyder E. ^{[3
]}

Kinmonth A.L. ^{[4
]}

Neil A. ^{[5
]}

机构：

[1] Department of Primary Health Care, University of Oxford, Old Road Campus, Oxford

[2] School of Sport and Exercise Sciences, University of Birmingham, Birmingham

[3] School of Health and Related Research, University of Sheffield, Sheffield, S1 4DA

[4] General Practice and Primary Care Research Unit, University of Cambridge, Cambridge, CB2 2SR, Robinson Way

[5] Oxford Centre for Diabetes, Endocrinology and Metebolism Churchill Hospital, Headington, Oxford

来源：

BMC Family Practice | / 6卷 / 1期

关键词：

Glycaemic Control; Assessment Visit; Tight Glycaemic Control; Parallel Group Trial; Common Sense Model;

D O I：

10.1186/1471-2296-6-25

中图分类号：

学科分类号：

摘要：

Background: We do not yet know how to use blood glucose self-monitoring (BGSM) most effectively in the selfmanagement of type 2 diabetes treated with oral medication. Training in monitoring may be most effective in improving glycaemic control and well being when results are linked to behavioural change. Methods/design: DiGEM is a three arm randomised parallel group trial set in UK general practices. A total of 450 patients with type 2 diabetes managed with lifestyle or oral glucose lowering medication are included. The trial compares effectiveness of three strategies for monitoring glycaemic control over 12 months (1) a control group with three monthly HbA1c measurements; interpreted with nurse-practitioner; (2) A self-testing of blood glucose group; interpreted with nurse- practitioner to inform adjustment of medication in addition to 1; (3) A self-monitoring of blood glucose group with personal use of results to interpret results in relation to lifestyle changes in addition to 1 and 2. The trial has an 80% power at a 5% level of significance to detect a difference in change in the primary outcome, HbA1c of 0.5% between groups, allowing for an attrition rate of 10%. Secondary outcome measures include health service costs, well-being, and the intervention effect in sub-groups defined by duration of diabetes, current management, health status at baseline and co-morbidity. A mediation analysis will explore the extent to which changes in beliefs about selfmanagement of diabetes between experimental groups leads to changes in outcomes in accordance with the Common Sense Model of illness. The study is open and has recruited more than half the target sample. The trial is expected to report in 2007. Discussion: The DiGEM intervention and trial design address weaknesses of previous research by use of a sample size with power to detect a clinically significant change in HbA1c, recruitment from a well-characterised primary care population, definition of feasible monitoring and behaviour change strategies based on psychological theory and evidence, and measures along the hypothesised causal path from cognitions to behaviours and disease and well being related outcomes. The trial will provide evidence to support, focus or discourage use of specific BGSM strategies. © 2005 Farmer et al; licensee BioMed Central Ltd.

引用

共 29 条

[11] Karter A.J., Ackerson L.M., Darbinian J.A., D'Agostino R.B., Ferrara A., Liu J., Selby J.V., Self-monitoring of blood glucose levels and glycaemic control: The Northern Kaiser Permanente Registry, Am J Med, 111, pp. 1-9, (2002)
[12] Coster S., Gulliford M.C., Seed P.T., Powrie J.K., Swaminatham R., Self-monitoring in Type 2 diabetes mellitus: A meta-analysis, Diabet Med, 17, pp. 755-761, (2000)
[13] Halimi S., Apports de "auto surveillance glycemique dans la prise en charge des diabetique insulino (DID) et non insulino dependents (DNID), Diabetes Metab (Paris), 24, pp. 35-41, (1998)
[14] Faas A., Schellevis F.G., Van Eijk J.T., The efficacy of self monitoring of blood glucose in NIDDM subjects: A criteria-based literature review, Diabetes Care, 20, pp. 1482-1486, (1997)
[15] Schwedes U., Siebolds M., Mertes G., Meal-Related Structured Self-Monitoring of Blood Glucose: Effect on diabetes control in non-insulin-treated type 2 diabetic patients, Diabetes Care, 25, pp. 1928-1932, (2002)
[16] Guerci B., Drouin P., Grange V., Bougneres P., Fontaine P., Kerlan V., Passa P., Thivolet C., Vialettes B., Charbonnel B., Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: The Auto-Surveillance Intervention Active (ASIA) study, Diabetes Metab, 29, pp. 587-594, (2003)
[17] Fox M.A., Cassmeyer V., Eaks G.A., Hamera E., O'Connell K., Knapp T., Blood glucose self-monitoring usage and its influence on patients' perceptions of diabetes, Diabetes Educ, 10, pp. 27-31, (1984)
[18] Leventhal H., Nerenz D.R., Steele D.J., Illness representations and coping with health threats, Handbook of Psychology and Health, pp. 219-252, (1984)
[19] Hampson S.E., Glasgow R.E., Toobert D.J., Personal models of diabetes and their relations to self-care activities, Health Psychol, 9, pp. 632-646, (1990)
[20] Hampson S.E., Glasgow R.E., Foster L.S., Personal models of diabetes among older adults: Relationship to self-management and other variables, Diabetes Educ, 21, pp. 300-307, (1995)

← 1 2 3 →